2024, Cardiovascular Imaging and Coronary Artery Disease

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

FEBRUARY 13, 2024

Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. In Press European Heart Journal CV Imag 2024.This

Coronary Artery Disease

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging

Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve

DAIC

FEBRUARY 23, 2024

milla1cf Fri, 02/23/2024 - 11:54 February 23, 2024 — Cleerly , the company creating a new standard of care to aid in the diagnosis of heart disease, announced that its recently U.S. Derivation, Validation and Prognostic Assessment of an AI-Based Algorithm for Determination of Coronary Ischemia: The CREDENCE and PACIFIC Trial.

Ischemia

Ischemia Coronary Artery Disease Physiology Cardiovascular Imaging

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

DAIC

JANUARY 17, 2024

©Science China Press milla1cf Wed, 01/17/2024 - 16:04 January 17, 2024 — This review was jointly published by Prof. AI has shown great potential and advantages in many aspects of CCTA, including image quality optimization, fully automated calculation, quantitative and qualitative evaluation, etc.

Technology

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.

Ischemia

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease

Society of Cardiovascular Computed Tomography Annual Scientific Meeting SCCT24 Preview

DAIC

JUNE 27, 2024

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual Scientific Meeting, SCCT24, “At the heart of it,” to be held July 18-21, in Washington, DC. A Welcome Reception will close out the day in the exhibit hall from 6:00 p.m. - for all attendees. 3:00 p.m. . - 5:00 p.m.,

Congenital Heart Disease

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease

Impact of Absolute Myocardial Blood Flow Quantification on the Diagnostic Performance of PET-Based Perfusion Scans Using 82Rubidium

Circulation: Cardiovascular Imaging

JANUARY 15, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e016138, January 1, 2024. BACKGROUND:Guidelines propose the inclusion of quantitative measurements from82Rubidium positron emission tomography (RbPET) to discriminate obstructive coronary artery disease (CAD).

Coronary Artery Disease

Coronary Artery Disease Stenosis Cardiovascular Imaging Circulation

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

DAIC

MAY 14, 2024

2 “We continue to see an evolution in how clinicians work to treat cardiovascular disease and want to give clinicians the tools, along with the flexibility and adaptability, they need to enable better outcomes for their patients,” says Arnaud Marie – General Manager for Global Intervention at GE HealthCare. “In Accessed May 2024.

Coronary Artery Disease

Coronary Artery Disease Interventional Cardiology Innovation Physiology

Cleerly Raises $106 Million in Series C Extension Funding

DAIC

DECEMBER 5, 2024

tim.hodson Thu, 12/05/2024 - 11:59 Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 million. Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence.

Coronary Artery Disease

Coronary Artery Disease Medicare Plaque Technology

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

JUNE 12, 2024

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

Ultrasound

Ultrasound Cardio Oncology Technology Congenital Heart Disease

The Evolving Computed Tomography Market

DAIC

MARCH 7, 2024

As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 billion by 2029, growing at a CAGR of 5.86% in the forecast period (2024-2029), according to a new report released by Mordor Intelligence. billion, and expected to reach $3.18

Technology

Technology Document Cardiovascular Imaging Cancer

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

DAIC

MAY 23, 2024

milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging.

Plaque

Plaque Coronary Artery Disease Technology Anatomy

Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability

Circulation: Cardiovascular Imaging

FEBRUARY 19, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 2 , Page e016178, February 1, 2024. Women were older (median age, 71 versus 65 years;P<0.001) and had less severe coronary artery disease with a lower plaque burden than men. Hounsfield units; moderate inflammation, −73.0 Hounsfield units).RESULTS:A

Plaque

Plaque Coronary Artery Disease Laboratory Cardiovascular Imaging

Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant

Circulation: Cardiovascular Imaging

JANUARY 15, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e015858, January 1, 2024. BACKGROUND:Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. Normal PET was associated with the lowest risk of MACE (2.2%/year year versus 3.6%/year

Transplant

Transplant Coronary Artery Disease Myocardial Infarction Kidney Disease

Sex Differences in Coronary Inflammation and Atherosclerosis Phenotypes in Response to Imaging Marker of Stress-Related Neural Activity

Circulation: Cardiovascular Imaging

FEBRUARY 19, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 2 , Page e016057, February 1, 2024. BACKGROUND:Sex-specific differences in coronary phenotypes in response to stress have not been elucidated.

Atherosclerosis

Atherosclerosis Plaque Coronary Artery Disease Biomarkers

Cardiovascular Update

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

Webinars

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

Society of Cardiovascular Computed Tomography Annual Scientific Meeting SCCT24 Preview

Impact of Absolute Myocardial Blood Flow Quantification on the Diagnostic Performance of PET-Based Perfusion Scans Using 82Rubidium

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

Cleerly Raises $106 Million in Series C Extension Funding

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

The Evolving Computed Tomography Market

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability

Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant

Sex Differences in Coronary Inflammation and Atherosclerosis Phenotypes in Response to Imaging Marker of Stress-Related Neural Activity

Stay Connected